Published in Lab Law Weekly, January 6th, 2006
Sato was formerly president of Vertex Pharmaceuticals from 2000 to 2005. Prior to her position as president, she served as the company's chief scientific officer and Chair of the scientific advisory board. Sato is credited with establishing Vertex as a leading innovator in small molecule drug discovery and development, and under her leadership, the company built a robust pipeline of product candidates in the areas of viral disease, autoimmune diseases, and cancer, as well as a portfolio of collaborative partnerships.
Prior to joining Vertex,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly